Wuyi International Pharmaceutical Co Ltd (1889):企業財務及び戦略的SWOT分析

◆英語タイトル:Wuyi International Pharmaceutical Co Ltd (1889) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH139511FSA
◆発行会社(調査会社):GlobalData
◆発行日:2017年1月13日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,400見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Summary
Wuyi International Pharmaceutical Co Ltd (Wuyi International) is a specialty pharmaceutical company that manufactures, markets, and sells prescription and over-the-counter western pharmaceuticals and modern Chinese medicine injectable products. The company’s products include pediatric cough syrup, perilla oil capsular, glutamline injectable, manshan white syrup, fluconazole and glucose injectible, vitamin B12, alginic sodium diester, and dexamethasone, among others. Wuyi International’s products are used in the therapeutic areas of cardiovascular, respiratory, gastrointestinal and infectious diseases and cancer. The company markets its products through its sales, marketing and distribution network. Wuyi International is headquartered in Hong Kong.

Wuyi International Pharmaceutical Co Ltd Key Recent Developments

Oct 14, 2016: Wuyi International Pharmaceutical : Resignation of Director and Change of Member of Board Committee
Sep 30, 2016: Wuyi International: Change of Registered Office Address
Jun 30, 2016: Wuyi International Announces Board Changes
Apr 06, 2016: Wuyi International Pharmaceutical Company Annual Results Announcement For The Year Ended 31 December 2015 And Resumption Of Trading
Mar 03, 2016: Resignation Of Non-Executive Director: Wuyi International Pharmaceutical Company

This comprehensive SWOT profile of Wuyi International Pharmaceutical Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Wuyi International Pharmaceutical Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Wuyi International Pharmaceutical Co Ltd – Key Information
Wuyi International Pharmaceutical Co Ltd – Overview
Wuyi International Pharmaceutical Co Ltd – Key Employees
Wuyi International Pharmaceutical Co Ltd – Key Employee Biographies
Wuyi International Pharmaceutical Co Ltd – Key Operational Heads
Wuyi International Pharmaceutical Co Ltd – Major Products and Services
Wuyi International Pharmaceutical Co Ltd – History
Wuyi International Pharmaceutical Co Ltd – Company Statement
Wuyi International Pharmaceutical Co Ltd – Locations And Subsidiaries
Wuyi International Pharmaceutical Co Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Wuyi International Pharmaceutical Co Ltd – Business Description
Wuyi International Pharmaceutical Co Ltd – Corporate Strategy
Wuyi International Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Wuyi International Pharmaceutical Co Ltd – Strengths
Wuyi International Pharmaceutical Co Ltd – Weaknesses
Wuyi International Pharmaceutical Co Ltd – Opportunities
Wuyi International Pharmaceutical Co Ltd – Threats
Wuyi International Pharmaceutical Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Wuyi International Pharmaceutical Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Wuyi International Pharmaceutical Co Ltd, Key Information
Wuyi International Pharmaceutical Co Ltd, Key Ratios
Wuyi International Pharmaceutical Co Ltd, Share Data
Wuyi International Pharmaceutical Co Ltd, Major Products and Services
Wuyi International Pharmaceutical Co Ltd, History
Wuyi International Pharmaceutical Co Ltd, Key Employees
Wuyi International Pharmaceutical Co Ltd, Key Employee Biographies
Wuyi International Pharmaceutical Co Ltd, Key Operational Heads
Wuyi International Pharmaceutical Co Ltd, Other Locations
Wuyi International Pharmaceutical Co Ltd, Subsidiaries
Wuyi International Pharmaceutical Co Ltd, Key Manufacturing facilities
Wuyi International Pharmaceutical Co Ltd, Key Competitors
Wuyi International Pharmaceutical Co Ltd, SWOT Analysis
Wuyi International Pharmaceutical Co Ltd, Ratios based on current share price
Wuyi International Pharmaceutical Co Ltd, Annual Ratios
Wuyi International Pharmaceutical Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Wuyi International Pharmaceutical Co Ltd, Performance Chart
Wuyi International Pharmaceutical Co Ltd, Ratio Charts

★調査レポート[Wuyi International Pharmaceutical Co Ltd (1889):企業財務及び戦略的SWOT分析] (コード:GDPH139511FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Wuyi International Pharmaceutical Co Ltd (1889):企業財務及び戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆